Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwan Chan

Showing results (141-150 of 161) with videos related to

Pageof 17
Sort By:
British Journal of Cancer|September 19, 2019
Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmesJohn Malcolm Nicholls, Victor Ho-Fun Lee, Sik-Kwan Chan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 18, 2024
Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancerChi Leung Chiang, Kenneth Sik Kwan Chan, Huaping Li, et al.
Practical Radiation Oncology|September 20, 2025
Long-Term Outcome of Stereotactically Designed Hypofractionated Image Guided Radiation Therapy in Large, Unresectable Hepatocellular CarcinomaNatalie Sean Man Wong, Francis Ann Shing Lee, Venus Wan Yan Lee, et al.
Cancers|April 23, 2022
An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal CarcinomaSik-Kwan Chan, Brian O'Sullivan, Shao Hui Huang, et al.
JCO Precision Oncology|July 1, 2026
Cross-Platform Gene Signature to Predict Survival Outcomes for Nasopharyngeal CarcinomaHuaping Li, Qiuyu Jing, James Chung Hang Chow, et al.
JHEP Reports : Innovation in Hepatology|July 8, 2024
Dual-tracer PET/CT in the management of hepatocellular carcinomaKeith Wan Hang Chiu, Chi Leung Chiang, Kenneth Sik Kwan Chan, et al.
The Canadian Journal of Cardiology|December 6, 2014
Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/Canadian Society of Cardiac Surgery position statement on revascularization--multivessel coronary artery diseaseKoon K Teo, Eric Cohen, Christopher Buller, et al.
Nature Communications|March 31, 2023
Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinomaJeff Yat-Fai Chung, Philip Chiu-Tsun Tang, Max Kam-Kwan Chan, et al.
Medrxiv : the Preprint Server for Health Sciences|May 15, 2024
Evidence that minocycline treatment confounds the interpretation of neurofilament as a biomarkerJuliana E Gentile, Christina Heiss, Taylor L Corridon, et al.
Liver Cancer|May 17, 2024
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular CarcinomaChi Leung Chiang, Francis Ann Shing Lee, Kenneth Sik Kwan Chan, et al.
Pageof 17

Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
British Journal of Cancer|September 19, 2019
Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmesJohn Malcolm Nicholls, Victor Ho-Fun Lee, Sik-Kwan Chan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 18, 2024
Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancerChi Leung Chiang, Kenneth Sik Kwan Chan, Huaping Li, et al.
Practical Radiation Oncology|September 20, 2025
Long-Term Outcome of Stereotactically Designed Hypofractionated Image Guided Radiation Therapy in Large, Unresectable Hepatocellular CarcinomaNatalie Sean Man Wong, Francis Ann Shing Lee, Venus Wan Yan Lee, et al.
Cancers|April 23, 2022
An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal CarcinomaSik-Kwan Chan, Brian O'Sullivan, Shao Hui Huang, et al.
JCO Precision Oncology|July 1, 2026
Cross-Platform Gene Signature to Predict Survival Outcomes for Nasopharyngeal CarcinomaHuaping Li, Qiuyu Jing, James Chung Hang Chow, et al.
JHEP Reports : Innovation in Hepatology|July 8, 2024
Dual-tracer PET/CT in the management of hepatocellular carcinomaKeith Wan Hang Chiu, Chi Leung Chiang, Kenneth Sik Kwan Chan, et al.
The Canadian Journal of Cardiology|December 6, 2014
Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/Canadian Society of Cardiac Surgery position statement on revascularization--multivessel coronary artery diseaseKoon K Teo, Eric Cohen, Christopher Buller, et al.
Nature Communications|March 31, 2023
Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinomaJeff Yat-Fai Chung, Philip Chiu-Tsun Tang, Max Kam-Kwan Chan, et al.
Medrxiv : the Preprint Server for Health Sciences|May 15, 2024
Evidence that minocycline treatment confounds the interpretation of neurofilament as a biomarkerJuliana E Gentile, Christina Heiss, Taylor L Corridon, et al.
Liver Cancer|May 17, 2024
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular CarcinomaChi Leung Chiang, Francis Ann Shing Lee, Kenneth Sik Kwan Chan, et al.
Pageof 17